SEC Form 4 · accession 0001144204-16-112312
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William James Kennedy
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 8, 2016 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 6, 2016 | A | 12,459 | $0.00 | A | 78,949 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a grant of restricted shares that will vest on June 14, 2019.